Over-the-Counter (OTC) drugs have become an essential part of modern healthcare systems by enabling individuals to manage common health conditions without requiring a doctor’s prescription. These medicines improve accessibility, reduce healthcare costs, and promote self-care, especially for minor ailments such as fever, cough, cold, acidity, allergies, and pain. In developing countries like India, where healthcare resources are often overburdened and unevenly distributed, OTC medicines play a particularly significant role in providing quick and affordable healthcare solutions. Unlike many developed nations, India does not have a formally defined OTC drug category. Instead, medicines that are not included under Schedule H, H1, or X of the Drugs and Cosmetics Rules, 1945 are generally treated as OTC products. This creates a unique regulatory environment where a large number of medicines are freely available despite the absence of a structured legal framework. As a result, the Indian OTC market has expanded rapidly, driven by increasing self-medication practices, rising healthcare awareness, growth of retail and digital pharmacies, aggressive pharmaceutical marketing, and changing consumer behaviour. This project aims to provide a comprehensive understanding of OTC drugs in India by examining their regulatory framework, market dynamics, and pharmaceutical marketing strategies. It explores the classification and therapeutic uses of OTC medicines, their benefits and risks, the role of pharmacists, current legal provisions under the Drugs and Cosmetics Act, and the comparison between Indian and international regulatory systems. The project also highlights the impact of digital platforms, social media, and consumer-driven marketing on the OTC sector while discussing major OTC brands and future growth opportunities in the Indian pharmaceutical market. Overall, the study emphasizes that while OTC drugs offer convenience, affordability, and wider healthcare access, their irrational use and weak regulation can pose serious public health risks. Therefore, achieving a balance between accessibility and patient safety through effective regulation, consumer awareness, and responsible pharmaceutical practices is essential for the future growth of the OTC sector in India.
Over-the-Counter (OTC) drugs have become an essential part of modern healthcare systems by enabling individuals to manage common health conditions without requiring a doctor’s prescription. These medicines improve accessibility, reduce healthcare costs, and promote self-care, especially for minor ailments such as fever, cough, cold, acidity, allergies, and pain. In developing countries like India, where healthcare resources are often overburdened and unevenly distributed, OTC medicines play a particularly significant role in providing quick and affordable healthcare solutions.
Unlike many developed nations, India does not have a formally defined OTC drug category. Instead, medicines that are not included under Schedule H, H1, or X of the Drugs and Cosmetics Rules, 1945 are generally treated as OTC products. This creates a unique regulatory environment where a large number of medicines are freely available despite the absence of a structured legal framework. As a result, the Indian OTC market has expanded rapidly, driven by increasing self-medication practices, rising healthcare awareness, growth of retail and digital pharmacies, aggressive pharmaceutical marketing, and changing consumer behaviour.
This project aims to provide a comprehensive understanding of OTC drugs in India by examining their regulatory framework, market dynamics, and pharmaceutical marketing strategies. It explores the classification and therapeutic uses of OTC medicines, their benefits and risks, the role of pharmacists, current legal provisions under the Drugs and Cosmetics Act, and the comparison between Indian and international regulatory systems. The project also highlights the impact of digital platforms, social media, and consumer-driven marketing on the OTC sector while discussing major OTC brands and future growth opportunities in the Indian pharmaceutical market.
Overall, the study emphasizes that while OTC drugs offer convenience, affordability, and wider healthcare access, their irrational use and weak regulation can pose serious public health risks. Therefore, achieving a balance between accessibility and patient safety through effective regulation, consumer awareness, and responsible pharmaceutical practices is essential for the future growth of the OTC sector in India.
Created using ChatSlide
This project, titled "OTC Drugs in India," supervised by Dr. P.K. Sahoo with researchers Cheshta, Mehak, Vansh, Rohan, and Navya, delves into the regulation, market dynamics, and marketing strategies of over-the-counter drugs in India. It contrasts the Indian context with global standards, seeking to understand the pharmaceutical impact on healthcare. Insights into market dynamics, regulatory challenges, and major brand case studies underpin the findings. Key recommendations include...